Ziqiang Wang
Jinan, 250062, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance.
Journal: Journal of translational medicine
Published: May 05, 2026
NEAT1 is a therapeutic target for reversing T-cell exhaustion in bladder cancer.
Journal: Journal for immunotherapy of cancer
Published: November 18, 2025
lncRNA EPB41L4A-AS1: A promising therapeutic target for aging and age-related diseases.
Journal: Mechanisms of ageing and development
Published: September 10, 2025
Histone modifications: Key players in Alzheimer's disease.
Journal: Mechanisms of ageing and development
Published: April 22, 2025
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review).
Journal: International journal of oncology
Published: December 13, 2023
EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance.
Journal: npj aging
Published: October 10, 2023
Integration of RNA-seq and ATAC-seq analyzes the effect of low dose neutron-γ radiation on gene expression of lymphocytes from oilfield logging workers.
Journal: Frontiers in chemistry
Published: July 31, 2023
lncRNA-mediated ceRNA network in bladder cancer.
Journal: Non-coding RNA research
Published: October 13, 2022
lncRNA NEAT1: Key player in neurodegenerative diseases.
Journal: Ageing research reviews
Published: September 16, 2022
Non-coding RNAs: Key players in T cell exhaustion.
Journal: Frontiers in immunology
Published: June 02, 2022
Down-regulation of EPB41L4A-AS1 mediated the brain aging and neurodegenerative diseases via damaging synthesis of NAD+ and ATP.
Journal: Cell & bioscience
Published: September 22, 2021
NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential.
Journal: International journal of biological sciences
Published: May 13, 2021
Last Updated: 09/26/2026